Infectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...

With COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in...

Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...